Motley Fool Asset Management’s Zimmer Biomet ZBH Stock Holding History

Motley Fool Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41,200	Closed	-$4.13M	–	80
2016 Q4	$4.13M	Hold	41,200	–	–	0.92%	46
2016 Q3	$5.2M	Sell	41,200 -27,810	-40%	-$3.44M	1.15%	40
2016 Q2	$8.06M	Hold	69,010	–	–	1.76%	20
2016 Q1	$7.14M	Buy	69,010 +27,810	+68%	+$2.69M	1.5%	24
2015 Q4	$6.87M	Sell	41,200 -27,810	-40%	-$2.72M	1.38%	28
2015 Q3	$6.29M	Buy	69,010 +27,810	+68%	+$2.79M	1.23%	30
2015 Q2	$4.37M	Buy	41,200 +5,150	+14%	+$570K	0.78%	52
2015 Q1	$4.11M	Hold	36,050	–	–	0.72%	55
2014 Q4	$3.97M	Hold	36,050	–	–	0.75%	48
2014 Q3	$3.52M	Hold	36,050	–	–	0.73%	50
2014 Q2	$3.63M	Hold	36,050	–	–	0.78%	50
2014 Q1	$3.31M	Hold	36,050	–	–	0.77%	50
2013 Q4	$3.26M	Hold	36,050	–	–	0.82%	48
2013 Q3	$2.88M	Hold	36,050	–	–	0.86%	45
2013 Q2	$2.62M	Buy	+36,050	New	+$2.7M	0.95%	41

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Motley Fool Asset Management's ZBH Position: Q1 2017 in Review

Motley Fool Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 41,200 shares — an estimated $4.13M sold.

Motley Fool Asset Management first reported a position in ZBH in Q2 2013 and held it in 15 quarters. The position peaked at $8.06M in Q2 2016. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

Motley Fool Asset Management reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
Motley Fool Asset Management sold 41,200 Zimmer Biomet shares in Q1 2017, an estimated $4.13M.
Motley Fool Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 15 quarters.
Motley Fool Asset Management's Zimmer Biomet position peaked at $8.06M in Q2 2016.
817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Motley Fool Asset Management's 13F filing for Q1 2017, filed 9 May 2017.